Table 1. Prevalence of HCV infection in different geographic areas of China.
| Area (authors) |
Reporting year |
Characteristics of subjects |
No. of subjects |
Prevalence of HCV infection |
Testing method | Reference no. |
| Beijing (Sherlock) |
1993 | apparently healthy people | 164 | 6% | First-generation antibody test | 20 |
| Jiangsu (Ito) |
1994 | blood donors | 451 | 0.7%: anti-HCV 0.2%: HCV RNA |
Second-generation antibody test (Dinabo Co, Japan) and ELISA (Ortho Co. USA), and HCV RNA |
21 |
| Gansu (Wu, Mizokami) |
1995 | blood donors (40 volunteer donors and 80 paid donors) |
120 | Volunteer donor: 2.5%; Paid donor: 35% |
EIA 2 (Ortho Diagnostics, Raritan, NJ) | 22 |
| Guanxi (Yuan) |
1996 | hospitalized patients (non-liver disease) |
141 | 0.7% | ELISA Version 2.0 (Ortho Diagnostics, Raritan, NJ) | 23 |
| Henan (Zhang, Qiao) |
2005 | residents aged ≥55 years (participants in an interventional study) | 500 | 9.6% | ELISA Version 3.0 (Ortho Diagnostics, Raritan, NJ) | 24 |
| Henan (Liu) |
2009 | participants in esophageal cancer screening (age 25–65 years) |
8226 | 0.9% | HCV ELISA 3.0 (Autobio Co. Zhengzhou, China) |
25 |